Skip to main content
Skip to footer
Home
News Channels
All News
Reports
Press Room
Contact Us
About Us
Search ...
All Categories
Antibodies
DNA RNA and Cells
More News
Proteins and Peptides
Small Molecules
Vaccines
Results
Reports
May 2020
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective
2.050,00€
Mar 2020
Blockbuster Biologics 2019: Sales of Recombinant Therapeutic Antibodies & Proteins
90,00€
Sep 2019
RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective
2.050,00€
Jun 2019
Bispecific Antibodies for Immuno-Oncology & Other Diseases
800,00€
Jun 2019
Report Package: Bispecific Antibodies
3.150,00€
2.500,00€
Jun 2019
T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis
2.350,00€
Mar 2019
Blockbuster Biologics 2018: Sales of Recombinant Therapeutic Antibodies & Proteins
80,00€
May 2018
Report Package: TCR-Based Antibody and T-Cell Immunotherapy
4.450,00€
2.670,00€
May 2018
TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals
2.150,00€
Mar 2018
Blockbuster Biologics 2017: Sales of Recombinant Therapeutic Antibodies & Proteins
80,00€
Jan 2018
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends
2.300,00€
2.000,00€
Jul 2024
FcRn Inhibitors Pipeline Review
200,00€
←
1
2
3
Search ...
Report categories
Antibody & Protein Sales
Antibody Technologies
Biosimilar Antibodies & Proteins
CAR T-Cells
Drug the Undruggable Technologies
Immuno-Oncology
mRNA Vaccines & Therapeutics
NK Cells & CAR Macrophages
Pipeline Database
RNA-Targeted Therapeutics
Target Pipelines
TCR T-Cells and Antibodies
Therapeutic Antibodies
Therapeutic Proteins & Peptides